LOX/LOXL in pulmonary fibrosis: potential therapeutic targets

L Chen, S Li, W Li - Journal of drug targeting, 2019 - Taylor & Francis
Lysyl oxidase (LOX) and lysyl oxidase-like proteins (LOXL), a family of extracellular matrix
(ECM) crosslinking enzymes that have been recognised as playing an important role in …
被引用次数：70 相关文章

[引用][C] LOX/LOXL in pulmonary fibrosis: potential therapeutic targets

L Chen, S Li, W Li - Journal of Drug Targeting, 2018 - cir.nii.ac.jp
LOX/LOXL in pulmonary fibrosis: potential therapeutic targets | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

LOX/LOXL in pulmonary fibrosis: potential therapeutic targets

L Chen, S Li, W Li - Journal of drug targeting, 2019 - pubmed.ncbi.nlm.nih.gov
Lysyl oxidase (LOX) and lysyl oxidase-like proteins (LOXL), a family of extracellular matrix
(ECM) crosslinking enzymes that have been recognised as playing an important role in …

LOX/LOXL in pulmonary fibrosis: potential therapeutic targets.

L Chen, S Li, W Li - Journal of Drug Targeting, 2018 - europepmc.org
Lysyl oxidase (LOX) and lysyl oxidase-like proteins (LOXL), a family of extracellular matrix
(ECM) crosslinking enzymes that have been recognised as playing an important role in …